Malaria: Relative Bioavailability and Food Effect of DSM265

NCT03637517 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: DSM265-TPGS 34% SDD, 400 mg fasted
DRUG: DSM265-TPGS 34% SDD, 400 mg fed
DRUG: DSM265 25% SDD, 400 mg fasted

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]